Results 41 to 50 of about 5,500,616 (251)

Safety of monitoring antiretroviral therapy response in HIV-1 infection using CD4+ T cell count at long-term intervals

Cadernos de Saúde Pública, 2018
: The latest Brazilian guideline recommended the reduction of routine CD4+ T cell counts for the monitoring of patients with human immunodeficiency virus type 1 (HIV-1) under combination antiretroviral therapy (cART).
Ingridt Hildegard Vogler, Daniela Frizon Alfieri, Heloisa Damazio Bruna Gianjacomo, Elaine Regina Delicato de Almeida, Edna Maria Vissoci Reiche   +4 more
doaj   +1 more source

Predictive Factors for Sustained Remission after Discontinuation of Antiviral Therapy in Patients with HBeAg-positive Chronic Hepatitis B

The Korean Journal of Gastroenterology, 2016
Background : /Aims: The optimal timing for discontinuing oral antiviral therapy in patients with HBeAg-positive chronic hepatitis B (CHB) is unclear. The aim of our study was to investigate sustained remission after stopping antiviral therapy in patients
Baek Gyu Jun, Sae Hwan Lee, Hong Soo Kim, Sang Gyune Kim, Young Seok Kim, Boo Sung Kim, Soung Won Jeong, Jae Young Jang, Young Don Kim, Gab Jin Cheon   +9 more
doaj   +1 more source

Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study

Metabolism Open, 2021
Background and aim: The incidence of hepatocellular carcinoma (HCC) decreases significantly in chronic hepatitis C (CHC) patients with sustained virologic response (SVR) after pegylated-interferon plus ribavirin (PR) or direct-acting antiviral (DAAs ...
Dong Ji, Guo-feng Chen, Xiao-xia Niu, Mingjie Zhang, Cheng Wang, Qing Shao, Vanessa Wu, Yudong Wang, Gregory Cheng, Selwyn J. Hurwitz, Raymond F. Schinazi, George Lau   +11 more
doaj   +1 more source

Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment

Libyan Journal of Medicine, 2021
Background/Aims. Despite the high efficacy and safety of direct-acting antivirals against hepatitis C virus shown in clinical trials, treatment failures continue to occur.
María E. Cárdaba-García, Encarnación Abad-Lecha, Miguel Á. Calleja-Hernández   +2 more
doaj   +1 more source

Sustained Virologic Response.

, 2016
Overall sustained virologic response, stratified by stage of fibrosis. The graph indicates the number of patient who achieved undetectable HCV viral load at 12 weeks post-treatment.
Martha Pavlakis (3153936), Nahel Elias (3153927), Meghan E. Sise (731751), Anil Chandraker (3153945), Steve Gabardi (3153954), Eliot C. Heher (3153942), Anna E. Rutherford (3153930), Michael P. Curry (3153957), Leonardo V. Riella (613107), Raymond T. Chung (214536), Ming V. Lin (3153939), Jasmine M. Hanifi (3153951), Donald Chute (3153948), Beth M. Amundsen (3153933)   +13 more
core   +1 more source

Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir

Cureus, 2023
Hepatitis C, a single-stranded RNA virus officially discovered in 1989, is one of the most known viruses of the Flaviviridae family. Direct-acting antiviral drugs helped revolutionize the management of hepatitis C infection by guaranteeing higher cure rates.
Abi-Saleh, Simon P, Ghazal, Fatima, Urtasun Sotil, Eva   +2 more
openaire   +2 more sources

Univariate and multivariate analysis of clinical and virologic characteristics predisposing patients to sustained virologic response.

, 2014
Univariate and multivariate analysis of clinical and virologic characteristics predisposing patients to sustained virologic response.
Tsung-Hsing Hung (579080), Kuo-Chih Tseng (579081), Chih-Wei Tseng (579076), Shu-Fen Wu (352137), Ching-Chih Lee (113210), Shinn-Jia Tzeng (579078), Ting-Tsung Chang (170605), Yu-Hsi Hsieh (579079), Chi-Yi Chen (579077)   +8 more
core   +1 more source

Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma

JGH Open, 2022
Background and Aim The risk of hepatocellular carcinoma (HCC) persists in a condition of sustained virologic response (SVR) after hepatitis C virus (HCV) eradication.
Keishi Sugimachi, Hiromitsu Araki, Hideyuki Saito, Takaaki Masuda, Fumihito Miura, Kentaro Inoue, Tomonari Shimagaki, Yohei Mano, Tomohiro Iguchi, Masaru Morita, Yasushi Toh, Tomoharu Yoshizumi, Takashi Ito, Koshi Mimori   +13 more
doaj   +1 more source

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis [PDF]

, 2007
BACKGROUND: Clinical outcomes of chronic hepatitis C infection in patients with advanced fibrosis include liver failure, hepatocellular carcinoma, and death.
Reichen, Juerg, Hansen, Bettina E, Hofmann, W Peter, Heathcote, E Jenny, Schalm, Solko W, Veldt, Bart J, Wedemeyer, Heiner, Manns, Michael P, Janssen, Harry L A, Zeuzem, Stefan   +9 more
core  

Anti-RR is not related to sustained virologic response.

, 2013
The frequency of samples with RR IIF-HEp-2 pattern, other patterns and those with a negative test was equivalent in patients exhibiting sustained virologic response and those classified as non-responders.
Gerson Dierley Keppeke (306084), Eduardo Antônio Benedito Silva (306087), Celso Granato (306088), Luís Eduardo C. Andrade (306090), Eunice Nunes (306085), Maria Lucia Gomes Ferraz (306086), Edward K. L. Chan (306089)   +6 more
core   +1 more source